Abstract
Background/Objectives: Participation in cervical cancer screening is the cornerstone of cervical cancer detection. Latvia has a low attendance rate for cervical cancer screening and a relatively high incidence of cervical cancer. HPV self-sampling is an alternative strategy to improve cervical cancer screening program compliance. The study aims to evaluate the acceptability of
self-sampling for human papillomavirus (HPV) testing in the population of Latvian women.
Methods: From February till October 2021women who attended the colposcopy unit in Riga Eastern Clinical University Hospital for known cervical pathology were invited to participate in the study. They were asked to perform unsupervised HPV self-sampling using written instructions, and after the procedure was asked to fill in the questionnaire regarding the course and
admissibility of the procedure. The study was approved by the Ethics Committee of Riga Stradiņš University.
Results: A total of 262 women were invited to participate in the study. 237 (90.5 %) participants agreed to provide a self-sample; of them, 93 (35.5 %) women found self-sampling acceptable and equivalent to the clinician-administered test. 134 (51.1 %) of patients reported that they would like to have a test carried out by a medical professional next time. Nineteen females (7.3 %) graded their feelings during the self-sampling test as "'embarrassed during the procedure'' or "'strongly embarrassed during the procedure''. 37 (14.1%) participants recorded mild or severe discomfort during the procedure. On the other hand, 36 (13.7 %) patients felt strong self-confidence during self-sampling, and 20 (7.6%) participants were interested or intensely interested in taking the test.
Conclusions: Self-sampling for HPV testing was acceptable in many patients, and women could carry out the test alone, using simple written instructions. The main arguments against performing self-sampling were shame regarding this procedure and discomfort during the procedure. This issue will need to be addressed if self-sampling is introduced.
self-sampling for human papillomavirus (HPV) testing in the population of Latvian women.
Methods: From February till October 2021women who attended the colposcopy unit in Riga Eastern Clinical University Hospital for known cervical pathology were invited to participate in the study. They were asked to perform unsupervised HPV self-sampling using written instructions, and after the procedure was asked to fill in the questionnaire regarding the course and
admissibility of the procedure. The study was approved by the Ethics Committee of Riga Stradiņš University.
Results: A total of 262 women were invited to participate in the study. 237 (90.5 %) participants agreed to provide a self-sample; of them, 93 (35.5 %) women found self-sampling acceptable and equivalent to the clinician-administered test. 134 (51.1 %) of patients reported that they would like to have a test carried out by a medical professional next time. Nineteen females (7.3 %) graded their feelings during the self-sampling test as "'embarrassed during the procedure'' or "'strongly embarrassed during the procedure''. 37 (14.1%) participants recorded mild or severe discomfort during the procedure. On the other hand, 36 (13.7 %) patients felt strong self-confidence during self-sampling, and 20 (7.6%) participants were interested or intensely interested in taking the test.
Conclusions: Self-sampling for HPV testing was acceptable in many patients, and women could carry out the test alone, using simple written instructions. The main arguments against performing self-sampling were shame regarding this procedure and discomfort during the procedure. This issue will need to be addressed if self-sampling is introduced.
| Original language | English |
|---|---|
| Pages | 3637 |
| Number of pages | 1 |
| Publication status | Published - Apr 2022 |
| Event | EUROGIN 2022 - Germany, Dusseldorf, Germany Duration: 10 Apr 2022 → 12 Apr 2022 https://www.eurogin.com/content/dam/Informa/eurogin/2022/pdf/Eurogin2022-Overview.pdf https://www.eurogin.com/en/program-cme/program-overview.html https://www.eurogin.com/en/home.html |
Congress
| Congress | EUROGIN 2022 |
|---|---|
| Abbreviated title | EUROGIN |
| Country/Territory | Germany |
| City | Dusseldorf |
| Period | 10/04/22 → 12/04/22 |
| Other | EUROGIN - International multidisciplinary HPV Congress |
| Internet address |
Field of Science*
- 3.2 Clinical medicine
Publication Type*
- 3.4. Other publications in conference proceedings (including local)
